ACIU logo

AC Immune SA (ACIU) EBITDA

Annual EBITDA

-$57.72 M
+$13.60 M+19.07%

December 31, 2023

Summary

Performance

1-Year Change

+19.07%

3-Year Change

+9.46%

5-Year Change

-13.72%

15-Year Change

-121.38%

ACIU EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

29.69%
ACIU annual EBITDA is higher than 29.69% of companies in Healthcare sector

High & Low

All-time High

$49.38 M
ACIU annual EBITDA is currently -216.89% below its historical high of $49.38 million

3-Year Low

-$76.60 M

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
ACIU previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

N/A
ACIU next annual earnings announcement has not yet been scheduled

OtherACIUprofitabilitymetrics:

Annual Revenue

$16.48 M
ACIU annual revenue is $16.48 million

Annual Net Income

-$60.40 M
ACIU annual net profit is -$60.40 million

Annual EBIT

-$60.19 M
ACIU annual earnings before interest & taxes is -$60.19 million

Annual EPS

-$0.71
ACIU annual earnings per share is -$0.71

Quarterly EBITDA

$7.01 M
+$31.54 M+128.60%

September 30, 2024

Summary

Performance

3-Month Change

+128.6%

1-Year Change

+135.49%

3-Year Change

+152.69%

5-Year Change

-63.11%

ACIU Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

80.51%
ACIU quarterly EBITDA is higher than 80.51% of companies in Healthcare sector

High & Low

All-time High

$65.30 M
ACIU quarterly EBITDA is currently -89.26% below its historical high of $65.30 million

3-Year Low

-$24.52 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
ACIU previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

N/A
ACIU next earnings announcement has not yet been scheduled

OtherACIUprofitabilitymetrics:

Quarterly Revenue

$29.47 M
ACIU quarterly revenue is $29.47 million

Quarterly Net Income

$6.36 M
ACIU quarterly net profit is $6.36 million

Quarterly EBIT

$6.40 M
ACIU quarterly earnings before interest & taxes is $6.40 million

Quarterly EPS

$0.06
ACIU quarterly earnings per share is $0.06

TTM EBITDA

-$41.97 M
+$23.51 M+35.90%

September 30, 2024

Summary

Performance

3-Month Change

+35.9%

1-Year Change

+28.92%

3-Year Change

+43.84%

5-Year Change

-184.9%

ACIU TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

34.75%
ACIU TTM EBITDA is higher than 34.75% of companies in Healthcare sector

High & Low

All-time High

$54.16 M
ACIU TTM EBITDA is currently -177.49% below its historical high of $54.16 million

3-Year Low

-$78.31 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
ACIU previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

N/A
ACIU next earnings announcement has not yet been scheduled

OtherACIUprofitabilitymetrics:

TTM Revenue

$46.93 M
ACIU TTM revenue is $46.93 million

TTM Net Income

-$44.59 M
ACIU TTM net profit is -$44.59 million

TTM EBIT

-$44.45 M
ACIU TTM earnings before interest & taxes is -$44.45 million

TTM EPS

-$0.46
ACIU TTM earnings per share is -$0.46

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

Annual EBITDA

-$57.72 M
ACIU annual EBITDA is -$57.72 million

Annual Net Income

-$60.40 M
ACIU annual net profit is -$60.40 million

Annual Interest Expense

$196.00 K
ACIU annual interest expense is $196.00 thousand

Annual Income Tax

$11.10 K
ACIU annual income tax is $11.10 thousand

Annual D&A

$2.47 M
ACIU annual depreciation & amortization is $2.47 million

ACIU EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+19.1%+135.5%+28.9%
3 y3 years+9.5%+152.7%+43.8%
5 y5 years-13.7%-63.1%-184.9%

ACIU EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+24.6%at high+128.6%at high+46.4%
5 y5-year-216.9%+24.6%at high+128.6%-184.9%+46.9%
alltimeall time-216.9%+24.6%-89.3%+128.6%-177.5%+46.9%

AC Immune SA EBITDA History

DateAnnualQuarterlyTTM
Sep 2024
-
$7.01 M(-128.6%)
-$41.97 M(-35.9%)
Jun 2024
-
-$24.52 M(+24.1%)
-$65.47 M(+10.9%)
Mar 2024
-
-$19.76 M(+320.8%)
-$59.04 M(+2.7%)
Dec 2023
-$57.72 M(-19.1%)
-$4.70 M(-71.5%)
-$57.47 M(-19.8%)
Sep 2023
-
-$16.49 M(-8.8%)
-$71.63 M(+4.6%)
Jun 2023
-
-$18.09 M(-0.5%)
-$68.45 M(-2.2%)
Mar 2023
-
-$18.19 M(-3.5%)
-$69.98 M(-2.0%)
Dec 2022
-$71.33 M(-6.9%)
-$18.86 M(+41.6%)
-$71.38 M(-4.5%)
Sep 2022
-
-$13.31 M(-32.2%)
-$74.73 M(-4.0%)
Jun 2022
-
-$19.62 M(+0.2%)
-$77.87 M(-0.6%)
Mar 2022
-
-$19.59 M(-11.8%)
-$78.31 M(+2.2%)
Dec 2021
-$76.60 M(+20.1%)
-$22.21 M(+35.0%)
-$76.59 M(+1.6%)
Sep 2021
-
-$16.45 M(-18.0%)
-$75.35 M(-4.6%)
Jun 2021
-
-$20.06 M(+12.3%)
-$78.97 M(+5.7%)
Mar 2021
-
-$17.87 M(-14.8%)
-$74.68 M(+16.3%)
Dec 2020
-$63.75 M(-229.1%)
-$20.98 M(+4.6%)
-$64.21 M(+3.3%)
Sep 2020
-
-$20.06 M(+27.1%)
-$62.16 M(+169.2%)
Jun 2020
-
-$15.78 M(+113.4%)
-$23.09 M(-0.7%)
Mar 2020
-
-$7.40 M(-60.9%)
-$23.27 M(-147.1%)
Dec 2019
$49.38 M
-$18.93 M(-199.6%)
$49.43 M(-8.7%)
DateAnnualQuarterlyTTM
Sep 2019
-
$19.01 M(-219.2%)
$54.16 M(+149.6%)
Jun 2019
-
-$15.95 M(-124.4%)
$21.70 M(-18.5%)
Mar 2019
-
$65.30 M(-559.8%)
$26.61 M(-152.5%)
Dec 2018
-$50.76 M(+94.7%)
-$14.20 M(+5.6%)
-$50.72 M(+58.2%)
Sep 2018
-
-$13.45 M(+21.8%)
-$32.05 M(+16.3%)
Jun 2018
-
-$11.04 M(-8.2%)
-$27.56 M(-4.3%)
Mar 2018
-
-$12.03 M(-369.6%)
-$28.82 M(+10.4%)
Dec 2017
-$26.07 M(+277.1%)
$4.46 M(-149.8%)
-$26.11 M(-25.9%)
Sep 2017
-
-$8.96 M(-27.1%)
-$35.24 M(-0.9%)
Jun 2017
-
-$12.29 M(+32.0%)
-$35.55 M(+260.9%)
Mar 2017
-
-$9.32 M(+99.2%)
-$9.85 M(+56.5%)
Dec 2016
-$6.91 M(-132.4%)
-$4.68 M(-49.5%)
-$6.29 M(-12.4%)
Sep 2016
-
-$9.27 M(-169.1%)
-$7.18 M(-131.2%)
Jun 2016
-
$13.41 M(-332.9%)
$23.05 M(+22.4%)
Mar 2016
-
-$5.76 M(+3.4%)
$18.83 M(-12.6%)
Dec 2015
$21.36 M(+76.7%)
-$5.57 M(-126.5%)
$21.55 M(-20.5%)
Sep 2015
-
$20.96 M(+128.1%)
$27.11 M(+341.0%)
Jun 2015
-
$9.19 M(-402.2%)
$6.15 M(-302.2%)
Mar 2015
-
-$3.04 M
-$3.04 M
Dec 2014
$12.09 M
-
-

FAQ

  • What is AC Immune SA annual EBITDA?
  • What is the all time high annual EBITDA for AC Immune SA?
  • What is AC Immune SA annual EBITDA year-on-year change?
  • What is AC Immune SA quarterly EBITDA?
  • What is the all time high quarterly EBITDA for AC Immune SA?
  • What is AC Immune SA quarterly EBITDA year-on-year change?
  • What is AC Immune SA TTM EBITDA?
  • What is the all time high TTM EBITDA for AC Immune SA?
  • What is AC Immune SA TTM EBITDA year-on-year change?

What is AC Immune SA annual EBITDA?

The current annual EBITDA of ACIU is -$57.72 M

What is the all time high annual EBITDA for AC Immune SA?

AC Immune SA all-time high annual EBITDA is $49.38 M

What is AC Immune SA annual EBITDA year-on-year change?

Over the past year, ACIU annual EBITDA has changed by +$13.60 M (+19.07%)

What is AC Immune SA quarterly EBITDA?

The current quarterly EBITDA of ACIU is $7.01 M

What is the all time high quarterly EBITDA for AC Immune SA?

AC Immune SA all-time high quarterly EBITDA is $65.30 M

What is AC Immune SA quarterly EBITDA year-on-year change?

Over the past year, ACIU quarterly EBITDA has changed by +$26.77 M (+135.49%)

What is AC Immune SA TTM EBITDA?

The current TTM EBITDA of ACIU is -$41.97 M

What is the all time high TTM EBITDA for AC Immune SA?

AC Immune SA all-time high TTM EBITDA is $54.16 M

What is AC Immune SA TTM EBITDA year-on-year change?

Over the past year, ACIU TTM EBITDA has changed by +$17.08 M (+28.92%)